phase readout

NCT07381764: ROMANCE: "Irinotecan Plus Cetuximab Rechallenge Versus Trifluridine/Tipiracil Plus Bevacizumab in Molecularly Selected Metastatic Colorectal Cancer"

NOT_YET_RECRUITINGupdated 1mo ago

community read0 votes

Sponsor: Gruppo Oncologico Italia Meridionale. Phase: PHASE2. Conditions: Metastatic Colorectal Cancer (CRC)

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

last refreshed 1h ago

Found something off?